Daniel Kalinovsky
0000-0001-8773-2797
Publication & Citation Trends
Publications
0 total
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells OA
Cited by 24
Semantic Scholar
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4 OA
Cited by 9
Semantic Scholar
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors OA
Cited by 33
Semantic Scholar
RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype OA
Cited by 41
Semantic Scholar
Properties of a cryptic lysyl oxidase from haloarchaeon Haloterrigena turkmenica OA
Cited by 2
Semantic Scholar
Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations.
Cited by 97
Semantic Scholar
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy OA
Cited by 160
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(6)
Monoclonal and Polyclonal Antibodies Research
(6)
Neuroblastoma Research and Treatments
(6)
Glycosylation and Glycoproteins Research
(5)
Microbial metabolism and enzyme function
(4)
Affiliations
Lomonosov Moscow State University
Moscow State University of Fine Chemical Technologies
Institute of Bioorganic Chemistry
Institute of Bioorganic Chemistry